Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Chemotherapy for patients with circulating tumour DNA-positive, stage II colon cancer (CIRCULATE)-an AIO/ABCSG trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Same author

Tracing TET1 expression in prostate cancer: discovery of malignant cells with a distinct oncogenic signature.

Clinical epigenetics·2021

Same author

Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.

Virchows Archiv : an international journal of pathology·2018

Same author

Management of patients with pancreatic cystic lesions: A case-based survey.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2017

Same author

[University Pathology in Germany].

Der Pathologe·2017

Same author

[Current biomarkers for gastric cancer].

Der Pathologe·2017

Same journal

[Connective (tissue) pathology: What brings us together!]

Der Pathologe·2022

Same journal

[Giant cell-containing tumors of bone and differential diagnoses].

Der Pathologe·2022

Same journal

[Automation and application of robotics in the pathology laboratory].

Der Pathologe·2022

Same journal

[Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification].

Der Pathologe·2022

Same journal

[Artificial intelligence: a solution for the lack of pathologists?]

Der Pathologe·2022

Same journal

[Predictive immunocytochemistry in non-small cell lung carcinoma].

Der Pathologe·2022

See all related articles

Search research articles

Related Experiment Video

Updated: May 29, 2026

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

[Serrated precursor lesions].

G B Baretton¹, D E Aust

¹Institut für Pathologie, Universitätsklinikum Carl Gustav Carus, TU Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland. gustavo.baretton@uniklinikum-dresden.de

|September 15, 2011

Summary

This summary is machine-generated.

The serrated pathway is a key route for colorectal cancer development, initiated by BRAF or KRAS mutations. This pathway involves epigenetic changes and includes precancerous lesions like sessile serrated adenomas.

More Related Videos

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Published on: February 16, 2024

Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights

Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights

Published on: October 13, 2023

Related Experiment Videos

Last Updated: May 29, 2026

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Published on: February 16, 2024

Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights

Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights

Published on: October 13, 2023

Area of Science:

Gastrointestinal Pathology
Molecular Oncology
Colorectal Cancer Research

Background:

The serrated pathway is recognized as a significant route in colorectal carcinogenesis.
Sessile serrated adenomas (SSA) and traditional serrated adenomas (TSA) are precursor lesions in this pathway.
This pathway involves distinct molecular alterations and epigenetic modifications.

Purpose of the Study:

To elucidate the molecular mechanisms driving the serrated pathway of colorectal cancer.
To highlight the role of specific genetic mutations (BRAF, KRAS) and epigenetic changes.
To emphasize the clinical significance of understanding this pathway for tumor management.

Main Methods:

Review of current literature on serrated pathway colorectal carcinogenesis.
Analysis of molecular alterations including oncogene mutations (BRAF, KRAS).
Examination of epigenetic modifications, specifically CpG island hypermethylation.

Main Results:

Activating BRAF mutations initiate SSAs, while KRAS mutations initiate TSAs.
Epigenetic silencing of genes involved in cell cycle control and DNA repair occurs.
Lesions like SSAs, previously lacking dysplasia, are now recognized as precancerous.
Carcinomas arising from the serrated pathway exhibit variable biological behavior.

Conclusions:

The serrated pathway represents a distinct and critical mechanism of colorectal cancer development.
Understanding the molecular drivers and epigenetic landscape is crucial for accurate diagnosis and classification.
The biological variability of serrated pathway tumors necessitates tailored clinical management strategies.